DDIS-07. TG02, AN ORAL CDK INHIBITOR, INDUCES MULTIPLE CELL DEATH PATHWAYS IN HUMAN GLIOMA CELL LINES AND GLIOMA-INITIATING CELLS

TG02 is an orally bioavailable, multikinase inhibitor which potently inhibits cyclin-dependent kinases (CDK) 1, 2, 5, 7 and 9. CDK9-dependent depletion of short-lived oncoproteins such as MCL-1 and MYC has been proposed as its primary mechanism of cytotoxicity. Here we report that TG02 exhibits stro...

Full description

Saved in:
Bibliographic Details
Published in:Neuro Oncol
Main Authors: Le Rhun, Emilie, Achenbach, Caroline Von, Szabo, Emese, Weller, Michael
Format: Artigo
Language:Inglês
Published: Oxford University Press 2017
Subjects:
Abstracts
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692775/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.243
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items